Pharmacology of Heart Failure with focus on Omercamtiv Mecarbil.
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Department of Pharmacology and Pharmacotherapy | hu_HU |
| dc.contributor.author | Amachree, Ibaniyi | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponentdept | Kenézy Kórház Központi Aneszteziológiai és Intenzív Terápiás Osztály | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.date.accessioned | 2019-01-31T11:27:23Z | |
| dc.date.available | 2019-01-31T11:27:23Z | |
| dc.date.created | 2018-07-24 | |
| dc.description.abstract | Pharmacologically, different drugs can be used to tackle this major health concern. These drugs include; ACEi, Diuretics, Beta-blockers and so on. A new drug by the name of OM has been developed and this provides an alternative mode of action when in comparison to other positive inotropes. | hu_HU |
| dc.description.corrector | szg | |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 49 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/263458 | |
| dc.language.iso | en | hu_HU |
| dc.subject | Heart Failure | hu_HU |
| dc.subject.dspace | Pharmacotherapy | hu_HU |
| dc.title | Pharmacology of Heart Failure with focus on Omercamtiv Mecarbil. | hu_HU |